195 related articles for article (PubMed ID: 37056729)
1. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
3. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
Zhou Y; Li Y; Hamblin MR; Wen X
Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
[TBL] [Abstract][Full Text] [Related]
5. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
[TBL] [Abstract][Full Text] [Related]
6. The role of 755-nm alexandrite picosecond laser in melasma management.
Pulumati A; Jaalouk D; Algarin YA; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
[TBL] [Abstract][Full Text] [Related]
8. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.
Badawi AM; Osman MA
Clin Cosmet Investig Dermatol; 2018; 11():13-20. PubMed ID: 29379308
[TBL] [Abstract][Full Text] [Related]
9. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
10. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
[No Abstract] [Full Text] [Related]
12. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
Mendoza CG; Singzon IA; Handog EB
Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
[TBL] [Abstract][Full Text] [Related]
13. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
14. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
Yue B; Yang Q; Xu J; Lu Z
Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
[TBL] [Abstract][Full Text] [Related]
16. The Split-Face Comparison of the Combined Er-YAG Laser and Hydroquinone 4% With Hydroquinone 4% Alone in the Treatment of Melasma in Iranian Patients: A Prospective, Interventional Case Study.
Namazi N; Hesami A; Ketabi Y
J Lasers Med Sci; 2020; 11(1):70-73. PubMed ID: 32099630
[No Abstract] [Full Text] [Related]
17. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma.
Pazyar N; Yaghoobi R; Zeynalie M; Vala S
Clin Cosmet Investig Dermatol; 2019; 12():115-122. PubMed ID: 30858717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial.
Ge Y; Yang Y; Guo L; Zhang M; Wu Q; Zeng R; Rong H; Jia G; Shi H; Fang J; Lin T
J Am Acad Dermatol; 2020 Aug; 83(2):397-403. PubMed ID: 30885760
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuvenation: a multicenter, randomized, double-blinded, split-face study in Chinese patients.
Li Y; Yao C; Zhang H; Li L; Song Y
Lasers Med Sci; 2022 Sep; 37(7):2879-2887. PubMed ID: 35501519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
